Breadcrumb
NIH Guide: Weekly Index for March 6, 2020
Weekly NIH Funding Opportunities and Notices
March 6, 2020
Policy Notices
-
RESCINDED - Notice on Policy Regarding Minimum Level of Effort for NCI-Funded Awards
(NOT-CA-20-033)National Cancer Institute
General Notices
-
Notice of Information: Sunsetting of the NIA Caloric Restricted Aging Colony
(NOT-AG-20-020)National Institute on Aging
-
Clarification of NIDDK Policy Regarding Ancillary Studies to Multi-Center Clinical Studies
(NOT-DK-20-014)National Institute of Diabetes and Digestive and Kidney Diseases
-
Webinar for Biological Research Needs for High Spatial Resolution Imaging Supported by the Department of Energy and the National Institutes of Health
(NOT-GM-20-024)National Institute of General Medical Sciences
-
Notice to Announce NHLBI's Participation in the Human Health Exposure Analysis Resource (HHEAR) Program
(NOT-HL-20-753)National Heart, Lung, and Blood Institute
-
Request for Information (RFI): Input to Advance Artificial Intelligence (AI)-ready Data Generation and Scalable Computational Approaches in NIAMS Research
(NOT-AR-20-009)National Institute of Arthritis and Musculoskeletal and Skin Diseases
Notice of Changes to Funding Opportunities
-
Notice of Change in Application Types Allowed for PAR-19-070 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
(NOT-AG-20-018)National Institute on Aging
-
Notice of Change in Application Types Allowed for PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
(NOT-AG-20-019)National Institute on Aging
-
Notice of Clarification for PAR-20-106, Centers for AIDS Research (P30 Clinical Trial Not Allowed)
(NOT-AI-20-037)National Institute of Allergy and Infectious Diseases
-
Notice of Clarification for PAR-20-107, Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
(NOT-AI-20-038)National Institute of Allergy and Infectious Diseases
-
Notice of NIDCD Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
(NOT-DC-20-002)National Institute on Deafness and Other Communication Disorders
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Cooperative Agreement, Clinical Trial Optional
(NOT-AA-20-004)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Intent to Publish a Funding Opportunity Announcement for Reissuing PAR-18-205 NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)
(NOT-EB-20-002)National Institute of Biomedical Imaging and Bioengineering
-
Notice of Intent to Publish a Funding Opportunity Announcement for NIOSH Centers of Excellence for Total Worker Health (U19)
(NOT-OH-20-005)National Institute for Occupational Safety and Health
Notices of Special Interest
-
Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders
(NOT-DA-20-005)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Mentored Career Development Award in Large-Scale Clinical Study Development and Analysis
(NOT-DA-20-006)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Harnessing computational tools for sophisticated analyses of Substance Use Disorder-related behaviors
(NOT-DA-20-017)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders
(NOT-DA-20-030)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain
(NOT-DA-20-039)National Institute on Drug Abuse
-
Notice of Special Interest: Expanding Genome Integrity Assays to Population Studies (Admin Supp Clinical Trial Not Allowed)
(NOT-ES-20-009)National Institute of Environmental Health SciencesNational Cancer Institute
-
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(NOT-NS-20-023)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchNational Center for Advancing Translational Sciences
-
Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
(NOT-OD-20-073)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational Sciences
Funding Opportunities
-
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(PAR-20-111)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): August 11, 2020, February 9, 2021,August 10, 2021,February 9, 2022,August 9, 2022, February 9, 2023 by 5:00 PM local time of applicant organization.
-
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD)
(U19 Clinical Trial Not Allowed)
(PAR-20-120)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(PAR-20-122)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): ?August 11, 2020, February 9, 2021, August 10, 2021, February 9, 2022 August 9, 2022, February 9, 2023
-
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
(PAR-20-123)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below:
-
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
(PAR-20-124)Food and Drug AdministrationApplication Receipt Date(s): June 1, 2020 by 11:59 PM Eastern Time. May 3, 2021 by 11:59 PM Eastern Time. May 2, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late Applications will not be accepted for this FOA
-
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
(PAR-20-125)National Institute of General Medical SciencesNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): July 24, 2020; June 24, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed)
(PAR-20-126)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): Standard dates apply The first standard application due date for this FOA is May 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
(PAR-20-127)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed)
(PAS-20-121)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed)
(RFA-AI-20-010)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed)
(RFA-AI-20-016)National Institute of Allergy and Infectious DiseasesNational Institute of Mental HealthApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
(RFA-AR-21-003)National Institute of Arthritis and Musculoskeletal and Skin DiseasesApplication Receipt Date(s): August 11, 2020, by 5:00 PM local time of applicant organization. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional)
(RFA-AT-21-001)National Center for Complementary and Integrative HealthNational Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): July 09, 2020
-
Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional)
(RFA-AT-21-002)National Center for Complementary and Integrative HealthNational Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): July 09, 2020
-
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
(RFA-CA-20-033)National Cancer InstituteApplication Receipt Date(s): August 3, 2020
-
Urological Epidemiology (UroEpi) Institutional Research Career Development Program (K12 - Independent Clinical Trial Not Allowed)
(RFA-DK-20-001)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): June 18, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional)
(RFA-NR-20-002)National Institute of Nursing ResearchNational Institute on Drug AbuseNational Institute of Mental HealthApplication Receipt Date(s): May 13, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Research Education Program Grants for CryoEM and CryoET Curriculum Development (R25 Clinical Trial Not Allowed)
(RFA-RM-20-010)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): July 24, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: November 14, 2024
For technical issues E-mail OER Webmaster